Related references
Note: Only part of the references are listed.MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical Care Setting
Luis Ostrosky-Zeichner et al.
CLINICAL INFECTIOUS DISEASES (2014)
Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?
A. Fekkar et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
What's new in the clinical and diagnostic management of invasive candidiasis in critically ill patients
Cristobal Leon et al.
INTENSIVE CARE MEDICINE (2014)
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality
Matteo Bassetti et al.
INTENSIVE CARE MEDICINE (2014)
Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010)
Olivier Lortholary et al.
INTENSIVE CARE MEDICINE (2014)
Application of marginal structural models in pharmacoepidemiologic studies: a systematic review
Shibing Yang et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)
β-Glucan Antigenemia Anticipates Diagnosis of Blood Culture-Negative Intraabdominal Candidiasis
Frederic Tissot et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Caspofungin MICs Correlate with Treatment Outcomes among Patients with Candida glabrata Invasive Candidiasis and Prior Echinocandin Exposure
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Finding the Missing 50% of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care
Cornelius J. Clancy et al.
CLINICAL INFECTIOUS DISEASES (2013)
Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
Barbara D. Alexander et al.
CLINICAL INFECTIOUS DISEASES (2013)
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012
R. Phillip Dellinger et al.
CRITICAL CARE MEDICINE (2013)
Candidaemia in the non-neutropenic patient: A critique of the guidelines
A. Deshpande et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
EMPIRICUS micafungin versus placebo during nosocomial sepsis in Candida multi-colonized ICU patients with multiple organ failures: study protocol for a randomized controlled trial
Jean-Francois Timsit et al.
TRIALS (2013)
Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source Control
Marin Kollef et al.
CLINICAL INFECTIOUS DISEASES (2012)
(1,3)-β-D-Glucan as a Prognostic Marker of Treatment Response in Invasive Candidiasis
Siraya Jaijakul et al.
CLINICAL INFECTIOUS DISEASES (2012)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
O. A. Cornely et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Systemic antifungal therapy in critically ill patients without invasive fungal infection
Elie Azoulay et al.
CRITICAL CARE MEDICINE (2012)
Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study
Alexis Tabah et al.
INTENSIVE CARE MEDICINE (2012)
Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes
Shellee A. Grim et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Correlation of Clinical Outcomes with β-Glucan Levels in Patients with Invasive Candidiasis
Charles R. Sims et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients
Olivier Lortholary et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study
Daniel H. Kett et al.
CRITICAL CARE MEDICINE (2011)
Antifungal use influences Candida species distribution and susceptibility in the intensive care unit
Pierre Fournier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Utility of time-dependent inverse-probability-of-treatment weights to analyze observational cohorts in the intensive care unit
Romain Pirracchio et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Usefulness of the Candida score for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study
Cristobal Leon et al.
CRITICAL CARE MEDICINE (2009)
Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study
C. Leon et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2009)
Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis
Benoit P. Guery et al.
INTENSIVE CARE MEDICINE (2009)
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Jean-Louis Vincent et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Constructing inverse probability weights for marginal structural models
Stephen R. Cole et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Empirical fluconazole versus placebo for intensive care unit patients - A randomized trial
Mindy G. Schuster et al.
ANNALS OF INTERNAL MEDICINE (2008)
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw et al.
CLINICAL INFECTIOUS DISEASES (2008)
Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting
L. Ostrosky-Zeichner et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2007)
Tracheostomy does not improve the outcome of patients requiring prolonged mechanical ventilation: A propensity analysis
Christophe Clec'h et al.
CRITICAL CARE MEDICINE (2007)
Excess risk of death from intensive care unit - Acquired nosocomial bloodstream infections: A reappraisal
M Garrouste-Orgeas et al.
CLINICAL INFECTIOUS DISEASES (2006)
Invasive candidiasis in the intensive care unit
L Ostrosky-Zeichner et al.
CRITICAL CARE MEDICINE (2006)
Candida as a risk factor for mortality in peritonitis
P Montravers et al.
CRITICAL CARE MEDICINE (2006)
A bedside scoring system (Candida score'') for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization
C León et al.
CRITICAL CARE MEDICINE (2006)
Candida spp. colonization significance in critically ill medical patients:: a prospective study
PE Charles et al.
INTENSIVE CARE MEDICINE (2005)
Epidemiology of candidemia in Swiss tertiary care hospitals:: Secular trends, 1991-2000
O Marchetti et al.
CLINICAL INFECTIOUS DISEASES (2004)
Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients
R Piarroux et al.
CRITICAL CARE MEDICINE (2004)
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
P Eggimann et al.
LANCET INFECTIOUS DISEASES (2003)
Marginal structural models and causal inference in epidemiology
JM Robins et al.
EPIDEMIOLOGY (2000)
Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men
MA Hernan et al.
EPIDEMIOLOGY (2000)
Share Paper
